Literature DB >> 29270814

Baseline data from a multicenter, 5-year, prospective cohort study of Japanese age-related macular degeneration: an AMD2000 report.

Akitaka Tsujikawa1, Yumiko Akagi-Kurashige2, Mitsuko Yuzawa3, Tatsuro Ishibashi4, Hideo Nakanishi2, Eiji Nakatani5, Satoshi Teramukai5,6, Masanori Fukushima5, Nagahisa Yoshimura2.   

Abstract

PURPOSE: To report research participants' baseline characteristics in the AMD2000 study, a prospective, multicenter, 5-year, observational cohort study of Japanese age-related macular degeneration (AMD). The characteristics were determined using multimodal imaging.
METHODS: Patients with AMD were recruited at 18 clinical sites in Japan between April 2006 and March 2009. Each patient underwent a complete ophthalmic examination, including measurement of best-corrected visual acuity (Landolt chart), indirect ophthalmoscopy, slit-lamp biomicroscopy with a contact lens, optical coherence tomography imaging, fundus photography, and fluorescein and indocyanine green angiography.
RESULTS: Four hundred sixty participants (326 men [70.9%]) were included in the study. At enrollment, 131 eyes (28.5%) had hard drusen and 125 eyes (27.2%) had soft drusen in the macular area. A total of 455 eyes (98.9%) were diagnosed as having wet AMD, and 5 eyes (1.1%), as having dry AMD. Of the 455 eyes with wet AMD, 209 eyes (45.4%) had typical AMD, 228 eyes (49.6%) had polypoidal choroidal vasculopathy (PCV), and 18 eyes (3.9%) had retinal angiomatous proliferation. The size of choroidal neovascularization (CNV) was significantly smaller with indocyanine green angiography than with fluorescein angiography (P < 0.001). Poor baseline visual acuity was associated with cystoid macular edema, older age, scar, extrafoveal macular edema, subfoveal CNV, large branching vascular network, and hard exudates.
CONCLUSION: Japanese patients with AMD are predominantly male, lack drusen, and have a high rate of PCV.

Entities:  

Keywords:  Age-related macular degeneration (AMD); Drusen; International classification; Multimodal imaging; Polypoidal choroidal vasculopathy

Mesh:

Year:  2017        PMID: 29270814     DOI: 10.1007/s10384-017-0556-3

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  38 in total

1.  Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy.

Authors:  H Iijima; M Imai; T Gohdo; S Tsukahara
Journal:  Am J Ophthalmol       Date:  1999-03       Impact factor: 5.258

2.  [Criteria for diagnosis of polypoidal choroidal vasculopathy].

Authors: 
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2005-07

3.  One-year outcomes of a treat-and-extend regimen of intravitreal aflibercept for polypoidal choroidal vasculopathy.

Authors:  Mio Hosokawa; Yuki Morizane; Masayuki Hirano; Shuhei Kimura; Fumiaki Kumase; Yusuke Shiode; Shinichiro Doi; Shinji Toshima; Mika Hosogi; Atsushi Fujiwara; Toshiharu Mitsuhashi; Fumio Shiraga
Journal:  Jpn J Ophthalmol       Date:  2016-12-07       Impact factor: 2.447

4.  Efficacy of intravitreal aflibercept in Japanese patients with exudative age-related macular degeneration.

Authors:  Masaaki Saito; Mariko Kano; Kanako Itagaki; Tetsuju Sekiryu
Journal:  Jpn J Ophthalmol       Date:  2016-09-22       Impact factor: 2.447

Review 5.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; J J Wang
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

6.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

7.  Association of clinical characteristics with disease subtypes, initial visual acuity, and visual prognosis in neovascular age-related macular degeneration.

Authors:  Yasuhiko Hirami; Michiko Mandai; Masayo Takahashi; Satoshi Teramukai; Harue Tada; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2009-09-08       Impact factor: 2.447

8.  Polypoidal choroidal vasculopathy with drusen.

Authors:  Daisuke Iwama; Akitaka Tsujikawa; Manabu Sasahara; Yasuhiko Hirami; Hiroshi Tamura; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2008-04-30       Impact factor: 2.447

Review 9.  Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians.

Authors:  Chee Wai Wong; Yasuo Yanagi; Won-Ki Lee; Yuichiro Ogura; Ian Yeo; Tien Yin Wong; Chui Ming Gemmy Cheung
Journal:  Prog Retin Eye Res       Date:  2016-04-14       Impact factor: 21.198

10.  Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Atsushi Otani; Manabu Sasahara; Yuko Yodoi; Hiroko Aikawa; Hiroshi Tamura; Akitaka Tsujikawa; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2007-04-30       Impact factor: 5.258

View more
  4 in total

1.  Association of an age-related maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Shunichiro Nakai; Wataru Matsumiya; Akiko Miki; Shigeru Honda; Makoto Nakamura
Journal:  Jpn J Ophthalmol       Date:  2019-08-02       Impact factor: 2.447

2.  Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy.

Authors:  Keiko Azuma; Atsushi Okubo; Yoko Nomura; Hanpeng Zhou; Ryo Terao; Yohei Hashimoto; Kimiko Shimizu Asano; Kunihiro Azuma; Tatsuya Inoue; Ryo Obata
Journal:  Sci Rep       Date:  2020-05-20       Impact factor: 4.379

3.  Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study.

Authors:  Kanji Takahashi; Masahito Ohji; Hiroko Terasaki; Shigeru Honda; Philippe Margaron; Tadhg Guerin; Mitsuko Yuzawa
Journal:  Clin Ophthalmol       Date:  2018-09-13

Review 4.  Effectiveness of Current Treatments for Wet Age-Related Macular Degeneration in Japan: A Systematic Review and Pooled Data Analysis.

Authors:  Kanji Takahashi; Tomohiro Iida; Susumu Ishida; Bruce Crawford; Yoko Sakai; Akikazu Mochizuki; Ryuta Tsujiuchi; Satoru Tanaka; Kota Imai
Journal:  Clin Ophthalmol       Date:  2022-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.